June 3rd, 2010

Tweets About Today’s Analyst Meeting on the MD&D Segment

Earlier today, senior leaders from our Medical Devices & Diagnostics segment (which, BTW, is the the company’s largest business segment) held a meeting with the investment community to highlight the new products, pipelines, geographic presence and other strategies that will sustain the long-term growth of this business. You can listen to a replay of the webcast on our website, but below are a few of the tweets I put out earlier today:

J&J holds analyst meeting highlighting growth strategies for its Medical Devices and Diagnostics (MD&D) segment http://bit.ly/cdY11k

Webcast of presentations for J&J MD&D analyst meeting on J&J website http://bit.ly/gNVaT

MD&D day will highlight new products, including blood glucose monitoring/hernia repair systems, disposable contacts http://bit.ly/agrGrp

Gorsky, WW Chair, MD&D segment: can grow in underpenetrated mrkts thru intro of more advanced products/organic growth http://bit.ly/agrGrp

MD&D received more than 12 reg approvals so far in ’10, plans to make about 80 significant submissions between ’10-’12 http://bit.ly/agrGrp

MD&D segment continues to globalize current portfolios by developing more localized products for different markets http://bit.ly/agrGrp

Leave a Reply

All comments will be reviewed before posting. Since this blog is about Johnson & Johnson, comments that don’t directly relate to the Company or to topics covered on this blog won’t be posted. Please see our comments policy for details.